Neoadjuvant Therapy Improves Survival in Metastatic Colon Cancer Neoadjuvant Therapy Improves Survival in Metastatic Colon Cancer

Among patients with metastatic colon cancer with liver or lung lesions who received neoadjuvant therapy, survival was longer in comparison with patients who received adjuvant therapy, but only in nonacademic settings.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news